Gain Therapeutics, Inc. financial data

Symbol
GANX on Nasdaq
Location
Bethesda, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 233% % -23.33%
Debt-to-equity 96% % 62%
Return On Equity -341% % -67.39%
Return On Assets -174% % -35.96%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36,097,536 shares 36%
Common Stock, Shares, Outstanding 35,976,390 shares 39%
Entity Public Float $30,800,000 USD -45.58%
Common Stock, Value, Issued $3,599 USD 39%
Weighted Average Number of Shares Outstanding, Basic 34,998,060 shares 32%
Weighted Average Number of Shares Outstanding, Diluted 34,998,060 shares 32%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $55,180 USD 23%
Revenue from Contract with Customer, Excluding Assessed Tax $55,180 USD 47%
Research and Development Expense $9,090,292 USD -23.87%
General and Administrative Expense $8,485,491 USD -10.55%
Operating Income (Loss) $-17,575,783 USD 18%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $-18,096,005 USD 15%
Income Tax Expense (Benefit) $1,295,740 USD 2,682%
Net Income (Loss) Attributable to Parent $-19,391,745 USD 9.2%
Earnings Per Share, Basic 0 USD/shares 47%
Earnings Per Share, Diluted 0 USD/shares 47%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $8,807,353 USD -26.91%
Marketable Securities, Current $2,019,414 USD -82.93%
Cash, Cash Equivalents, and Short-term Investments $12,700,000 USD
Assets, Current $10,517,268 USD -23.46%
Property, Plant and Equipment, Net $85,572 USD -28.46%
Operating Lease, Right-of-Use Asset $184,422 USD -34.5%
Assets $10,971,680 USD -23.63%
Accounts Payable, Current $1,577,151 USD 44%
Accrued Liabilities, Current $673,811 USD -49.57%
Liabilities, Current $4,170,602 USD -9.23%
Operating Lease, Liability, Noncurrent $65,026 USD -32.42%
Liabilities $5,062,250 USD -7.22%
Accumulated Other Comprehensive Income (Loss), Net of Tax $563,221 USD 132%
Retained Earnings (Accumulated Deficit) $-81,194,908 USD -33.58%
Stockholders' Equity Attributable to Parent $5,909,430 USD -33.67%
Liabilities and Equity $10,971,680 USD -23.63%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-3,821,527 USD -6.55%
Net Cash Provided by (Used in) Financing Activities $2,397,078 USD
Net Cash Provided by (Used in) Investing Activities $3,018,750 USD 43%
Common Stock, Shares Authorized 100,000,000 shares 100%
Common Stock, Shares, Issued 35,976,390 shares 39%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $-1,314,914 USD -13.73%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8,843,470 USD -26.81%
Deferred Tax Assets, Valuation Allowance $15,307,461 USD 27%
Deferred Tax Assets, Gross $15,310,335 USD 27%
Operating Lease, Liability $180,936 USD -34.21%
Depreciation $40,000 USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $-19,071,334 USD 10%
Lessee, Operating Lease, Liability, to be Paid $182,838 USD -34.36%
Property, Plant and Equipment, Gross $255,180 USD 5.8%
Operating Lease, Liability, Current $115,910 USD -35.17%
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,902 USD -46.44%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $102,161,036 USD 19%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years $174,585 USD -22.17%
Depreciation, Depletion and Amortization $20,660 USD 0.64%
Operating Leases, Future Minimum Payments Due, Next Twelve Months $234,576 USD -3.4%
Share-based Payment Arrangement, Expense $-438,877 USD -116.98%
Operating Leases, Future Minimum Payments, Due in Three Years $57,889 USD -64.87%
Operating Leases, Future Minimum Payments Due $467,050 USD -31.94%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%